Zaki Mohamed, Loubidi Mohammed, Bilgiç Tuğçe, Birim Derviş, Akssira Mohamed, Dagcı Taner, Berteina-Raboin Sabine, Saso Luciano, Khouili Mostafa, Armagan Güliz
Institut de Chimie Organique et Analytique ICOA, Pôle de Chimie, Université d'Orléans, UMR CNRS 7311, Rue de Chartres-BP 6759, CEDEX 2, 45067 Orléans, France.
Department of Science, Ecole Normale Supérieure, Moulay Ismail University, BP. 3104, Toulal, Meknés 50000, Morocco.
Pharmaceuticals (Basel). 2022 Mar 30;15(4):421. doi: 10.3390/ph15040421.
N-methyl-D-aspartate (NMDA) receptor stimulation may lead to excitotoxicity, which triggers neuronal death in brain disorders. In addition to current clinical therapeutic approaches, treatment strategies by phytochemicals or their derivatives are under investigation for neurodegenerative diseases. In the present study, novel amino and 1,2,3-triazole derivatives of tomentosin were prepared and tested for their protective and anti-apoptotic effects in NMDA-induced excitotoxicity. Amino-tomentosin derivatives were generated through a diastereoselective conjugate addition of several secondary amines to the α-methylene-γ-butyrolactone function, while the 1,2,3-triazolo-tomentosin was prepared by a regioselective Michael-type addition carried out in the presence of trimethylsilyl azide (TMSN) and the α-methylene-γ-lactone function. The intermediate key thus obtained underwent 1,3-dipolar Huisgen cycloaddition using a wide range of terminal alkynes. The possible effects of the derivatives on cell viability and free-radical production following NMDA treatment were measured by Water-Soluble Tetrazolium Salts (WST-1) and Dichlorofluorescein Diacetate (DCF-DA) assays, respectively. The alterations in apoptosis-related proteins were examined by Western blot technique. Our study provides evidence that synthesized triazolo- and amino-tomentosin derivatives show neuroprotective effects by increasing cellular viability, decreasing ROS production, and increasing the Bcl-2/Bax ratio in NMDA-induced excitotoxicity. The findings highlight particularly , , and as potential regulators and neuroprotective agents in NMDA overactivation.
N-甲基-D-天冬氨酸(NMDA)受体刺激可能导致兴奋性毒性,进而引发脑部疾病中的神经元死亡。除了当前的临床治疗方法外,植物化学物质及其衍生物的治疗策略也正在针对神经退行性疾病进行研究。在本研究中,制备了托美汀的新型氨基和1,2,3-三唑衍生物,并测试了它们在NMDA诱导的兴奋性毒性中的保护和抗凋亡作用。氨基托美汀衍生物是通过几种仲胺向α-亚甲基-γ-丁内酯官能团的非对映选择性共轭加成反应生成的,而1,2,3-三唑托美汀则是在叠氮三甲基硅烷(TMSN)和α-亚甲基-γ-内酯官能团存在下通过区域选择性迈克尔型加成反应制备的。由此获得的中间关键产物使用多种末端炔烃进行1,3-偶极胡伊斯根环加成反应。分别通过水溶性四唑盐(WST-1)和二氯荧光素二乙酸酯(DCF-DA)测定法测量NMDA处理后衍生物对细胞活力和自由基产生的可能影响。通过蛋白质印迹技术检测凋亡相关蛋白的变化。我们的研究提供了证据,表明合成的三唑和氨基托美汀衍生物通过提高细胞活力、减少活性氧生成以及增加NMDA诱导的兴奋性毒性中的Bcl-2/Bax比值来显示神经保护作用。这些发现特别突出了[此处可能有缺失内容]、[此处可能有缺失内容]和[此处可能有缺失内容]作为NMDA过度激活中的潜在调节剂和神经保护剂。